Oral cancer is a highly curable disease when it’s caught early.

In our continuing efforts to provide the most advanced technology and highest quality care available to our patients, this practice is proud to announce the inclusion of the ViziLite® Plus exam as an integral part of our annual comprehensive oral cancer screening program.

One person dies every hour from oral cancer in the United States – and the mortality has remained unchanged for more than 40 years. Alarmingly, more than 25% of oral cancer victims have no lifestyle risk factors (tobacco use). Clinical studies have determined that using ViziLite after the standard oral cancer examination improves the clinician’s ability to identify lesions suspicious for pathology. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effect of oral cancer. Proven screening technologies such as mammogram, Pap smear, PSA and colonoscopy offer the same types of early detection of cancer. ViziLite Plus is an easy and painless examination that gives this practice the best chance to find any oral abnormalities you may have at the earliest possible stage. This technology is the only medical device cleared by the FDA for the identification and monitoring of oral abnormalities in populations at increased risk for oral cancer.

Relative Oral cancer risk by patient profile:

Highest Risk: Patients age 40 and older and lifestyle risk factors (tobacco use); patients with a history of oral cancer

High Risk: Patients age 40 and older; tobacco user of any age

Increased Risk: Patient age 18 – 39